the role of tkis in the management of hepatocellular carcinoma
Published 1 year ago • 44 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
2:32
the role of systemic treatment in early-stage hepatocellular carcinoma
-
13:51
how to integrate new agents in hcc: the role of tkis
-
19:09
harnessing the kinome: multi-kinase inhibitors for the management of hepatocellular carcinoma
-
3:12
hcc whiteboard #3: the management of adverse events of tyrosine kinase inhibitors
-
1:19
the emerging role of checkpoint inhibitors in liver cancer
-
4:20
tyrosine kinase inhibitors (tkis) - imatinib (gleevec) - pharmacology - cml and all
-
45:53
hepatocellular carcinoma
-
5:32
introduction to egfr inhibitors
-
6:15
the clinical use of tyrosine kinase inhibitors in egfr-mutant nsclc
-
41:21
the role of tyrosine kinase inhibitors and mtor inhibitors
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:10
the impact of immunotherapy and checkpoint inhibition in treating hcc
-
4:58
hcc whiteboard #2: the mechanisms of action of tyrosine kinase inhibitors
-
0:52
the emerging role of t-cell engagers in sclc and neuroendocrine carcinomas
-
1:27
takeaways in hepatocellular carcinoma at asco gi 2023
-
1:16
assessing treatment options for hepatocellular carcinoma
-
4:53
checkpoint inhibition in hepatocellular carcinoma
-
3:56
novel developments in hcc treatment
-
1:18:47
"tkis: tyrosine kinase inhibitors & neuroendocrine tumors" • 2024 lacnets event • march 29, 2024
-
1:10
immuno-oncology agents plus tyrosine kinase inhibitors?
-
1:02
future directions of hcc treatment
-
1:13
choosing the best treatment regimen in advanced hepatocellular carcinoma